Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Angiodynamics Inc (NQ: ANGO )

18.20 USD -0.28 (-1.52%)
Official Closing Price Updated: 4:03 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Angiodynamics Inc

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
AngioDynamics Announces Resignation of CFO and Appointment of Interim CFO
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that Mark Frost... 
From GlobeNewswire News Releases
Analogic Announces Appointment of Mark Frost as New Chief Financial Officer
Analogic Corporation (Nasdaq:ALOG), enabling the world’s medical imaging and aviation security technology, today announced the appointment of Mark Frost as senior vice president, chief financial... 
From GlobeNewswire News Releases
An Update on Stocks under Momentum - Research on A10 Networks, AngioDynamics, TRAVELCENTERS OF AMERICA and Intersect ENT
Tags Business & Professional Services
From ACCESSWIRE
ALERT: Lundin Law PC Announces Investigation of AngioDynamics Inc. And Strongly Advises Shareholders With Losses In Excess of $50,000 To Contact The Firm
Lundin Law PC announces it is investigating claims against AngioDynamics Inc. (“AngioDynamics” or the “Company”) (Nasdaq: ANGO) concerning possible violations of federal securities laws. The... 
From Business Wire News Releases
Glancy Prongay & Murray Commences Investigation on Behalf of AngioDynamics Inc. Investors
Glancy Prongay & Murray Commences Investigation on Behalf of AngioDynamics Inc. Investors 
From Business Wire News Releases
Direction of Market Influences - Research on Cerus, Arena Pharmaceuticals, Walter Investment Management and AngioDynamics
Tags Business & Professional Services
From ACCESSWIRE
IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against AngioDynamics, Inc. and Encourages Investors to Contact the Firm
Goldberg Law PC (http://www.Goldberglawpc.com) announces that it is investigating claims of potential misrepresentations AngioDynamics, Inc. (“AngioDynamics” or the “Company”) (NASDAQ: ANGO). The... 
From Business Wire News Releases
The Wagner Firm Announces Investigation of AngioDynamics, Inc.
The Wagner Firm Announces Investigation of AngioDynamics, Inc. 
From Business Wire News Releases
AngioDynamics, Inc. (NASDAQ:ANGO) Shareholder Alert: Investigation over Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 10/15/2015 -- An investigation for shareholders in NASDAQ:ANGO shares was announced over potential breaches of fiduciary duties by certain directors at AngioDynamics, Inc. 
From SBWire - Latest Press Releases
AngioDynamics Announces the Approval of the NanoKnife System in South Korea
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that the... 
From GlobeNewswire News Releases
AngioDynamics Reports Fiscal 2016 First Quarter Results
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported financial... 
From GlobeNewswire News Releases
AngioDynamics, Inc. (NASDAQ:ANGO) Shareholder Alert: Investigation Concerning Possible Wrongdoing
San Diego, CA -- (SBWIRE) -- 10/08/2015 -- An investigation for shareholders in AngioDynamics, Inc. (NASDAQ:ANGO) shares was announced over potential breaches of fiduciary duties by certain directors... 
From SBWire - Latest Press Releases
AngioDynamics to Report Fiscal 2016 First Quarter Financial Results
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report... 
From GlobeNewswire News Releases
AngioDynamics to Present at the Morgan Stanley Global Healthcare Conference
From GlobeNewswire News Releases
Research Data Published in Annals of Surgery Concludes Irreversible Electroporation Utilizing NanoKnife Results in Substantially Prolonged Survival for Patients With Locally Advanced Pancreatic Cancer
From GlobeNewswire News Releases
AngioDynamics Announces First Patient Enrollment in RAPID Outcomes Database
From GlobeNewswire News Releases
AngioDynamics to Present at the 35th Annual Growth Conference
From GlobeNewswire News Releases
AngioDynamics Begins Shipment of New Midline Catheters
The New Product Category Launch is the Fourth Vascular Access Product Line to Include the Proprietary BioFlo Thromboresistant Material 
From GlobeNewswire News Releases
AngioDynamics Reports Fiscal 2015 Fourth Quarter and Full Year Financial Results
From GlobeNewswire News Releases
AngioDynamics to Report Fiscal 2015 Fourth Quarter and Full Year Financial Results
From GlobeNewswire News Releases
AngioDynamics to Present at the Jefferies 2015 Healthcare Conference
From GlobeNewswire News Releases
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Civil Securities Claims Against AngioDynamics, Inc. -- ANGO
From Business Wire News Releases
AngioDynamics to Present at the UBS Global Healthcare Conference
From GlobeNewswire News Releases
AngioDynamics to Present at the Bank of America Merrill Lynch Health Care Conference
From GlobeNewswire News Releases
ANGO INVESTOR ALERT: AngioDynamics, Inc. Shareholders Encouraged to Contact The Wagner Firm Regarding Investigation
From Business Wire News Releases
AngioDynamics, Inc. Investors Encouraged to Contact Securities Law Firm about Investigation into Allegations of Corporate Wrongdoing
From PR Newswire
AngioDynamics, Inc. (NASDAQ:ANGO) Investor Alert: Investigation over Possible Violations of Securities Laws
San Diego, CA -- (ReleaseWire) -- 04/20/2015 -- An investigation on behalf of investors of AngioDynamics, Inc. (NASDAQ:ANGO) shares over potential securities laws violations by AngioDynamics, Inc. and... 
From SBWire - Latest Press Releases
INVESTOR ALERT: Glancy Binkow & Goldberg LLP Investigates Claims on Behalf of Investors of AngioDynamics, Inc.
From Business Wire News Releases
SHAREHOLDER ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of AngioDynamics, Inc.
From Business Wire News Releases
AngioDynamics Re-Entering Embolization Market
Company Announces Worldwide Licensing Agreement With EmboMedics Inc. 
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.